日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Correction: Shivakumar et al. Synthesis, Characterization, and Enzyme Conjugation of Polycaprolactone Nanofibers for Tissue Engineering. Pharmaceutics 2025, 17, 953

更正:Shivakumar 等人,《聚己内酯纳米纤维的合成、表征及酶偶联在组织工程中的应用》,Pharmaceutics 2025, 17, 953

Shivakumar, Chandana B; Raju, Nithya Rani; Ramu, Pruthvi G; Vishwanath, Prashant M; Silina, Ekaterina; Stupin, Victor; Achar, Raghu Ram

Targeting autophagy in Duchenne muscular dystrophy: mechanistic insights and emerging therapeutic strategies

靶向自噬治疗杜氏肌营养不良症:机制解析与新兴治疗策略

Krishna, Lakshmi; Srivathsa, Ananyashree; Anand, Rhea; Rao, Anagha; Karnik, Medha; Vishwanath, Prashant; Dharmashekar, Chandan; Kumar Honnavalli, Yogish; Prashant, Akila

"Bridging the clinical, molecular and genetic perspectives on myocarditis in post-COVID-19 era"

“弥合新冠疫情后时代心肌炎的临床、分子和遗传学视角”

Birla, Siddharth; Angural, Arshia; Madathumchalil, Arya; Shende, Ritika V; Shastry, Sharvani V; Shekar, Pallavi Kanyappa; Mahadevappa, Manjappa; Vishwanath, Prashant; Prashant, Akila

Synthesis, Characterization, and Enzyme Conjugation of Polycaprolactone Nanofibers for Tissue Engineering

用于组织工程的聚己内酯纳米纤维的合成、表征和酶偶联

Shivakumar, Chandana B; Raju, Nithya Rani; Ramu, Pruthvi G; Vishwanath, Prashant M; Silina, Ekaterina; Stupin, Victor; Achar, Raghu Ram

A Brief Report on Identification of Splice Variants in an In Vitro 3D Spheroid Model for Differentiated Hepatocellular Carcinoma

关于在体外3D球状体模型中鉴定分化型肝细胞癌剪接变异体的简要报告

Karunakara, Shreyas H; Mehtani, Rohit; Ramaswamy, Gopalakrishna; Puttamallapa, Vinutha S; Vishwanath, Prashant M; Santhekadur, Prasanna K

Evaluating the Prophylactic and Nephroprotective Effects of Vitamin D and Metformin in Diabetic Nephropathy.

评估维生素 D 和二甲双胍对糖尿病肾病的预防和肾脏保护作用

B Ramegowda Lavanya, Vishwanath Prashant, V Salimath Paramahans, S Shetty Manjunath, K Marulaiah Srinath, C Ramachandra Shobha, Prashant Akila

Progression-free survival estimation of docetaxel-based second-line treatment for advanced non-small cell lung cancer: a pooled analysis from 18 randomized control trials

多西他赛二线治疗晚期非小细胞肺癌的无进展生存期估计:一项来自18项随机对照试验的汇总分析

N, Chaithra; Jain, Anisha; C, Sahana; Shreevatsa, Bhargav; Rajendrasozhan, Saravanan; Dharmashekar, Chandan; Suresh, Kuralayanapalya Puttahonnappa; Patil, Sharanagouda S; Singh, Pranav; Vishwanath, Prashant; Srinivasa, Chandrashekar; Kollur, Shiva Prasad; Shivamallu, Chandan

Molecular and Biochemical Therapeutic Strategies for Duchenne Muscular Dystrophy

杜氏肌营养不良症的分子和生化治疗策略

Krishna, Lakshmi; Prashant, Akila; Kumar, Yogish H; Paneyala, Shasthara; Patil, Siddaramappa J; Ramachandra, Shobha Chikkavaddaragudi; Vishwanath, Prashant

Unveiling Silent Consequences: Impact of Pulmonary Tuberculosis on Lung Health and Functional Wellbeing after Treatment

揭示无声的后果:肺结核治疗后对肺部健康和功能性健康的影响

Bansal, Nidhi; Arunachala, Sumalatha; Kaleem Ullah, Mohammed; Kulkarni, Shreedhar; Ravindran, Sukanya; ShankaraSetty, Rekha Vaddarahalli; Malamardi, Sowmya; Chaya, Sindaghatta Krishnarao; Lokesh, Komarla Sundararaja; Parthasarathi, Ashwaghosha; Shyam Prasad Shetty, Bellipady; Chikkahonnaiah, Prashanth; Vishwanath, Prashant; Siddaiah, Jayaraj Biligere; Mahesh, Padukudru Anand

Assessing the diagnostic potential of 16SrRNA gene for neonatal sepsis: A tertiary care hospital study in South India.

评估 16SrRNA 基因在新生儿败血症诊断中的潜力:印度南部一家三级医院的研究

Yadav Anshu Kumar, Nataraj Suma, Sharma Ritu, Vishwanath Prashant, Doddaiah Narayanappa, Murthy Srinivasa, Prashant Akila